|Articles|February 8, 2004
How do you measure the quality of life impact by melanoma?
Washington D.C. Sandra Bendeck, M.D. presented at the AADyesterday about ways that physicians can measure the quality of life impactby melanoma. Since the incidence of melanoma is increasing by four percentevery year, it is increasingly important to determine the impact of thisillness on patients, both physically and psychologically.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Delgocitinib Advances to Phase 3 Evaluation for Lichen Sclerosus
2
The Aesthetic Edge: January 2026
3
Case-Based Perspectives on Biologic Treatment for Hidradenitis Suppurativa
4
Atopia Therapeutics Reports Positive Preclinical Data for ATP-R13 as Disease-Modifying Oral AD Therapy
5






